| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antigens, CD1 | 94 | 2022 | 476 | 18.080 |
Why?
|
| Antigen Presentation | 58 | 2021 | 1303 | 6.120 |
Why?
|
| Mycobacterium tuberculosis | 55 | 2022 | 1837 | 5.690 |
Why?
|
| Lipids | 51 | 2022 | 3246 | 5.140 |
Why?
|
| Glycolipids | 34 | 2021 | 215 | 4.630 |
Why?
|
| T-Lymphocytes | 72 | 2022 | 10362 | 4.550 |
Why?
|
| Mycobacterium | 19 | 2019 | 258 | 3.760 |
Why?
|
| Antigens, Bacterial | 28 | 2021 | 1192 | 3.130 |
Why?
|
| Receptors, Antigen, T-Cell | 26 | 2022 | 2498 | 3.080 |
Why?
|
| Oxazoles | 13 | 2017 | 208 | 2.730 |
Why?
|
| T-Lymphocyte Subsets | 22 | 2021 | 1924 | 2.720 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 16 | 2019 | 821 | 2.580 |
Why?
|
| Lymphocyte Activation | 43 | 2021 | 5908 | 2.180 |
Why?
|
| Mycolic Acids | 10 | 2020 | 58 | 1.920 |
Why?
|
| Tuberculosis | 21 | 2022 | 1769 | 1.740 |
Why?
|
| Membrane Lipids | 6 | 2021 | 253 | 1.740 |
Why?
|
| Natural Killer T-Cells | 12 | 2021 | 329 | 1.680 |
Why?
|
| Glycoproteins | 11 | 2021 | 2309 | 1.560 |
Why?
|
| Lipopeptides | 5 | 2017 | 77 | 1.520 |
Why?
|
| Antigens | 10 | 2022 | 1507 | 1.420 |
Why?
|
| Phospholipids | 9 | 2021 | 813 | 1.380 |
Why?
|
| Antigens, CD1d | 9 | 2021 | 233 | 1.340 |
Why?
|
| Mycobacterium Infections | 5 | 2016 | 123 | 1.100 |
Why?
|
| Bacterial Proteins | 17 | 2020 | 3995 | 1.070 |
Why?
|
| Histocompatibility Antigens Class I | 9 | 2022 | 1418 | 1.050 |
Why?
|
| Autoantigens | 9 | 2022 | 914 | 1.050 |
Why?
|
| Trehalose | 5 | 2021 | 94 | 0.890 |
Why?
|
| Endosomes | 10 | 2015 | 531 | 0.880 |
Why?
|
| Skin | 9 | 2022 | 4325 | 0.830 |
Why?
|
| Protein Conformation | 12 | 2019 | 4057 | 0.830 |
Why?
|
| Galactosylceramides | 3 | 2017 | 98 | 0.810 |
Why?
|
| T-Cell Antigen Receptor Specificity | 3 | 2017 | 93 | 0.810 |
Why?
|
| Lipid Metabolism | 14 | 2017 | 1999 | 0.760 |
Why?
|
| Antacids | 1 | 2019 | 99 | 0.740 |
Why?
|
| Autoimmunity | 4 | 2018 | 1325 | 0.740 |
Why?
|
| Antigen-Presenting Cells | 10 | 2021 | 981 | 0.710 |
Why?
|
| Dendritic Cells | 12 | 2015 | 2726 | 0.700 |
Why?
|
| Tissue Donors | 3 | 2019 | 2147 | 0.690 |
Why?
|
| Phagosomes | 1 | 2019 | 212 | 0.680 |
Why?
|
| Lipoproteins | 7 | 2016 | 914 | 0.670 |
Why?
|
| Diglycerides | 3 | 2019 | 183 | 0.660 |
Why?
|
| Siderophores | 4 | 2022 | 64 | 0.640 |
Why?
|
| Models, Molecular | 14 | 2020 | 5525 | 0.630 |
Why?
|
| Amino Acid Motifs | 3 | 2019 | 965 | 0.630 |
Why?
|
| K562 Cells | 7 | 2021 | 640 | 0.620 |
Why?
|
| Cell Wall | 4 | 2017 | 451 | 0.610 |
Why?
|
| Terpenes | 2 | 2015 | 108 | 0.610 |
Why?
|
| Lysosomes | 7 | 2019 | 941 | 0.600 |
Why?
|
| Molecular Structure | 7 | 2020 | 1971 | 0.550 |
Why?
|
| Nucleosides | 1 | 2015 | 137 | 0.540 |
Why?
|
| Mass Spectrometry | 12 | 2020 | 2244 | 0.530 |
Why?
|
| Borrelia burgdorferi | 2 | 2019 | 174 | 0.530 |
Why?
|
| Antitubercular Agents | 3 | 2020 | 1294 | 0.530 |
Why?
|
| Virulence Factors | 2 | 2016 | 514 | 0.530 |
Why?
|
| Lectins, C-Type | 4 | 2021 | 617 | 0.520 |
Why?
|
| Rifampin | 1 | 2016 | 302 | 0.520 |
Why?
|
| Protein Multimerization | 5 | 2021 | 1001 | 0.520 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2014 | 88 | 0.500 |
Why?
|
| Protein Binding | 16 | 2020 | 9639 | 0.500 |
Why?
|
| Arylsulfonates | 2 | 2021 | 10 | 0.500 |
Why?
|
| HEK293 Cells | 7 | 2021 | 4310 | 0.480 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 5 | 2017 | 293 | 0.480 |
Why?
|
| Stereoisomerism | 9 | 2020 | 659 | 0.480 |
Why?
|
| Drug Resistance, Microbial | 1 | 2016 | 883 | 0.470 |
Why?
|
| Chromatography, High Pressure Liquid | 7 | 2016 | 1633 | 0.470 |
Why?
|
| Iron | 5 | 2022 | 1710 | 0.460 |
Why?
|
| Actinomycetales | 1 | 2012 | 33 | 0.460 |
Why?
|
| Benzofurans | 2 | 2021 | 151 | 0.460 |
Why?
|
| Carbohydrates | 2 | 2007 | 359 | 0.450 |
Why?
|
| Cord Factors | 2 | 2020 | 7 | 0.450 |
Why?
|
| Cell Line | 23 | 2021 | 16657 | 0.450 |
Why?
|
| Biosynthetic Pathways | 1 | 2012 | 141 | 0.410 |
Why?
|
| Mycobacterium kansasii | 2 | 2020 | 12 | 0.410 |
Why?
|
| Ligands | 11 | 2022 | 3297 | 0.400 |
Why?
|
| Animals | 61 | 2022 | 170486 | 0.400 |
Why?
|
| Ceramides | 1 | 2011 | 193 | 0.400 |
Why?
|
| Lyme Disease | 2 | 2019 | 606 | 0.390 |
Why?
|
| Humans | 126 | 2022 | 708843 | 0.380 |
Why?
|
| Models, Immunological | 5 | 2019 | 529 | 0.380 |
Why?
|
| Toll-Like Receptors | 3 | 2009 | 594 | 0.360 |
Why?
|
| Molecular Sequence Data | 15 | 2014 | 18748 | 0.360 |
Why?
|
| Histocompatibility Antigens Class II | 5 | 2019 | 1537 | 0.360 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 2021 | 813 | 0.340 |
Why?
|
| Minor Histocompatibility Antigens | 4 | 2022 | 322 | 0.330 |
Why?
|
| Salmonella typhi | 2 | 2019 | 175 | 0.330 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2022 | 340 | 0.330 |
Why?
|
| Mice | 33 | 2022 | 80876 | 0.310 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 2020 | 2635 | 0.310 |
Why?
|
| Structure-Activity Relationship | 7 | 2019 | 3209 | 0.300 |
Why?
|
| COP-Coated Vesicles | 2 | 2019 | 45 | 0.300 |
Why?
|
| Clone Cells | 5 | 2017 | 1767 | 0.290 |
Why?
|
| Viruses | 1 | 2009 | 350 | 0.290 |
Why?
|
| Bee Venoms | 2 | 2015 | 18 | 0.290 |
Why?
|
| Gene Expression Regulation, Bacterial | 5 | 2020 | 1156 | 0.280 |
Why?
|
| Crystallography, X-Ray | 7 | 2021 | 2008 | 0.280 |
Why?
|
| Interleukin-1beta | 1 | 2011 | 953 | 0.280 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2010 | 997 | 0.270 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 2005 | 100 | 0.270 |
Why?
|
| Amino Acid Sequence | 10 | 2014 | 14215 | 0.270 |
Why?
|
| Metabolomics | 1 | 2012 | 1357 | 0.250 |
Why?
|
| Macrolides | 1 | 2004 | 215 | 0.250 |
Why?
|
| Virus Diseases | 1 | 2009 | 674 | 0.250 |
Why?
|
| Graves Disease | 1 | 2005 | 249 | 0.250 |
Why?
|
| Latent Tuberculosis | 2 | 2016 | 189 | 0.240 |
Why?
|
| Monocytes | 4 | 2020 | 2660 | 0.240 |
Why?
|
| Toll-Like Receptor 2 | 3 | 2011 | 343 | 0.240 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2015 | 4254 | 0.230 |
Why?
|
| Mycobacterium bovis | 3 | 2016 | 159 | 0.230 |
Why?
|
| Databases, Factual | 3 | 2012 | 7763 | 0.230 |
Why?
|
| Cross Reactions | 4 | 2019 | 879 | 0.230 |
Why?
|
| Polyisoprenyl Phosphate Sugars | 1 | 2001 | 2 | 0.230 |
Why?
|
| Membrane Proteins | 4 | 2020 | 8072 | 0.230 |
Why?
|
| Membrane Transport Proteins | 2 | 2020 | 1024 | 0.230 |
Why?
|
| Embolism, Fat | 1 | 2002 | 56 | 0.220 |
Why?
|
| Flow Cytometry | 8 | 2016 | 6127 | 0.220 |
Why?
|
| Recombinant Proteins | 8 | 2017 | 6850 | 0.220 |
Why?
|
| Tuberculosis Vaccines | 2 | 2019 | 48 | 0.220 |
Why?
|
| Phosphatidylglycerols | 2 | 2022 | 47 | 0.210 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2001 | 356 | 0.210 |
Why?
|
| Signal Transduction | 4 | 2018 | 23950 | 0.210 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2020 | 35 | 0.200 |
Why?
|
| Balsams | 1 | 2020 | 6 | 0.200 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2000 | 33 | 0.200 |
Why?
|
| Bacterial Infections | 1 | 2009 | 1423 | 0.200 |
Why?
|
| Base Sequence | 8 | 2014 | 13352 | 0.200 |
Why?
|
| Cell Membrane | 6 | 2021 | 3892 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 4941 | 0.200 |
Why?
|
| Transfection | 5 | 2015 | 6161 | 0.200 |
Why?
|
| Models, Biological | 8 | 2014 | 9907 | 0.200 |
Why?
|
| Immunophenotyping | 3 | 2020 | 1908 | 0.200 |
Why?
|
| Intracranial Embolism | 1 | 2002 | 216 | 0.190 |
Why?
|
| Macrophages | 5 | 2020 | 5784 | 0.190 |
Why?
|
| Antigens, Plant | 1 | 2020 | 82 | 0.190 |
Why?
|
| Biological Transport | 5 | 2015 | 2146 | 0.190 |
Why?
|
| Phosphatidic Acids | 1 | 2019 | 51 | 0.190 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 3972 | 0.190 |
Why?
|
| Virulence | 4 | 2022 | 1324 | 0.180 |
Why?
|
| Group IV Phospholipases A2 | 2 | 2016 | 60 | 0.180 |
Why?
|
| Binding Sites | 3 | 2019 | 6276 | 0.180 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2002 | 491 | 0.180 |
Why?
|
| Endocytosis | 5 | 2014 | 1018 | 0.180 |
Why?
|
| Glycosylation | 5 | 2014 | 1127 | 0.180 |
Why?
|
| Mycobacterium leprae | 2 | 2017 | 97 | 0.170 |
Why?
|
| Dermatitis, Atopic | 2 | 2022 | 607 | 0.170 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2013 | 437 | 0.170 |
Why?
|
| Bacteria | 1 | 2009 | 2040 | 0.170 |
Why?
|
| Peptides | 3 | 2019 | 4424 | 0.160 |
Why?
|
| Hordeum | 1 | 2016 | 21 | 0.160 |
Why?
|
| Conserved Sequence | 3 | 2019 | 1246 | 0.160 |
Why?
|
| Leprosy | 1 | 2017 | 126 | 0.160 |
Why?
|
| Immunologic Techniques | 1 | 2017 | 227 | 0.160 |
Why?
|
| Coat Protein Complex I | 2 | 2019 | 37 | 0.160 |
Why?
|
| Sphingolipids | 1 | 2018 | 160 | 0.160 |
Why?
|
| Polyketide Synthases | 2 | 2017 | 25 | 0.150 |
Why?
|
| Genome, Plant | 1 | 2016 | 80 | 0.150 |
Why?
|
| Interleukin-2 | 4 | 2015 | 1936 | 0.150 |
Why?
|
| Langerhans Cells | 2 | 2022 | 176 | 0.150 |
Why?
|
| Quantitative Trait Loci | 2 | 2022 | 1976 | 0.150 |
Why?
|
| Receptors, Immunologic | 2 | 2020 | 1482 | 0.150 |
Why?
|
| Wasp Venoms | 1 | 2015 | 21 | 0.150 |
Why?
|
| Immunologic Memory | 2 | 2021 | 1391 | 0.150 |
Why?
|
| Killer Cells, Natural | 6 | 2012 | 2165 | 0.150 |
Why?
|
| Chromatography, Liquid | 3 | 2020 | 959 | 0.150 |
Why?
|
| Pyroglyphidae | 1 | 2016 | 84 | 0.140 |
Why?
|
| Fatty Acids | 4 | 2015 | 1741 | 0.140 |
Why?
|
| Dermatitis | 1 | 2017 | 194 | 0.140 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 2913 | 0.140 |
Why?
|
| Isomerism | 1 | 2015 | 207 | 0.140 |
Why?
|
| Histocompatibility Antigens | 2 | 2015 | 526 | 0.140 |
Why?
|
| Receptors, IgG | 2 | 2009 | 612 | 0.140 |
Why?
|
| Intermediate Filament Proteins | 1 | 2016 | 275 | 0.140 |
Why?
|
| Decidua | 1 | 2015 | 83 | 0.140 |
Why?
|
| Membrane Microdomains | 1 | 2016 | 212 | 0.140 |
Why?
|
| Enzyme-Linked Immunospot Assay | 2 | 2015 | 137 | 0.140 |
Why?
|
| Immunity | 2 | 2012 | 957 | 0.140 |
Why?
|
| Lactones | 1 | 2017 | 340 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 5 | 2016 | 4926 | 0.140 |
Why?
|
| Acyltransferases | 3 | 2017 | 305 | 0.130 |
Why?
|
| Cell Separation | 4 | 2016 | 1835 | 0.130 |
Why?
|
| Th17 Cells | 1 | 2021 | 742 | 0.130 |
Why?
|
| Allergens | 2 | 2020 | 1277 | 0.130 |
Why?
|
| Hand Strength | 1 | 2017 | 448 | 0.130 |
Why?
|
| Carbohydrate Conformation | 2 | 2007 | 204 | 0.130 |
Why?
|
| Chromatography, Thin Layer | 2 | 2012 | 243 | 0.130 |
Why?
|
| Gene Expression Regulation | 6 | 2022 | 12447 | 0.130 |
Why?
|
| Protein Isoforms | 5 | 2014 | 1712 | 0.130 |
Why?
|
| Milk | 1 | 2017 | 430 | 0.130 |
Why?
|
| Immunotherapy, Active | 1 | 1994 | 61 | 0.130 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2014 | 330 | 0.130 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 3812 | 0.130 |
Why?
|
| Peru | 3 | 2022 | 835 | 0.130 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 2159 | 0.130 |
Why?
|
| Epitopes | 3 | 2015 | 2646 | 0.130 |
Why?
|
| Biological Assay | 1 | 2017 | 662 | 0.130 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2017 | 1900 | 0.120 |
Why?
|
| Models, Chemical | 2 | 2009 | 644 | 0.120 |
Why?
|
| AIDS-Related Complex | 1 | 1993 | 110 | 0.120 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2012 | 756 | 0.120 |
Why?
|
| Genome | 1 | 2021 | 1747 | 0.120 |
Why?
|
| Prevalence | 2 | 2020 | 14712 | 0.120 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 312 | 0.120 |
Why?
|
| Propaganda | 1 | 1992 | 5 | 0.120 |
Why?
|
| Interferon-gamma | 7 | 2021 | 3245 | 0.120 |
Why?
|
| Saposins | 1 | 2012 | 17 | 0.110 |
Why?
|
| Mental Healing | 1 | 1992 | 30 | 0.110 |
Why?
|
| Books | 1 | 1992 | 25 | 0.110 |
Why?
|
| 5' Untranslated Regions | 1 | 2013 | 259 | 0.110 |
Why?
|
| Dimerization | 1 | 2014 | 909 | 0.110 |
Why?
|
| Protein Transport | 2 | 2013 | 2059 | 0.110 |
Why?
|
| Cattle | 3 | 2013 | 4006 | 0.110 |
Why?
|
| Hyperlipidemias | 1 | 2017 | 796 | 0.110 |
Why?
|
| Jurkat Cells | 3 | 2021 | 799 | 0.110 |
Why?
|
| Psoriasis | 2 | 2017 | 970 | 0.110 |
Why?
|
| Lectins | 1 | 2014 | 557 | 0.110 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2002 | 1343 | 0.110 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 1482 | 0.110 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2009 | 377 | 0.110 |
Why?
|
| Guinea Pigs | 1 | 2013 | 1432 | 0.100 |
Why?
|
| Erythema Chronicum Migrans | 1 | 2011 | 47 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2013 | 815 | 0.100 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2012 | 526 | 0.100 |
Why?
|
| Lysine | 2 | 2020 | 1026 | 0.100 |
Why?
|
| Food Hypersensitivity | 1 | 2018 | 619 | 0.100 |
Why?
|
| Software | 3 | 2021 | 4345 | 0.100 |
Why?
|
| Paratuberculosis | 1 | 2009 | 5 | 0.100 |
Why?
|
| Tuberculosis, Bovine | 1 | 2009 | 13 | 0.100 |
Why?
|
| Protein Structure, Quaternary | 1 | 2011 | 457 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2015 | 3700 | 0.100 |
Why?
|
| Glycerophospholipids | 1 | 2009 | 37 | 0.100 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2012 | 1001 | 0.100 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2020 | 1989 | 0.100 |
Why?
|
| Hydroxy Acids | 1 | 2009 | 18 | 0.100 |
Why?
|
| Lipopolysaccharides | 4 | 2013 | 2264 | 0.100 |
Why?
|
| Organ Specificity | 1 | 2015 | 2064 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2022 | 4383 | 0.090 |
Why?
|
| Antibody Specificity | 1 | 2011 | 1170 | 0.090 |
Why?
|
| Coculture Techniques | 4 | 2017 | 1374 | 0.090 |
Why?
|
| Methylation | 1 | 2012 | 1111 | 0.090 |
Why?
|
| Hepatitis B virus | 1 | 2012 | 444 | 0.090 |
Why?
|
| Escherichia coli | 4 | 2019 | 4316 | 0.090 |
Why?
|
| DNA Primers | 2 | 2012 | 3002 | 0.090 |
Why?
|
| Butyrates | 1 | 2009 | 170 | 0.090 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 18375 | 0.090 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2020 | 2930 | 0.090 |
Why?
|
| Hepatitis B, Chronic | 1 | 2012 | 343 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 3968 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2009 | 1897 | 0.080 |
Why?
|
| Species Specificity | 1 | 2013 | 2619 | 0.080 |
Why?
|
| Lung | 5 | 2022 | 9706 | 0.080 |
Why?
|
| Amino Acids | 2 | 2014 | 1752 | 0.080 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 903 | 0.080 |
Why?
|
| Hypersensitivity | 1 | 2015 | 1019 | 0.080 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2010 | 718 | 0.080 |
Why?
|
| Diazepam Binding Inhibitor | 1 | 2006 | 4 | 0.080 |
Why?
|
| CHO Cells | 2 | 2012 | 1438 | 0.080 |
Why?
|
| Biofilms | 1 | 2011 | 601 | 0.080 |
Why?
|
| Hydrogen Bonding | 2 | 2005 | 296 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 3 | 2002 | 6571 | 0.080 |
Why?
|
| Cells, Cultured | 8 | 2017 | 20170 | 0.080 |
Why?
|
| Peptide Synthases | 1 | 2006 | 83 | 0.080 |
Why?
|
| Evolution, Molecular | 2 | 2020 | 1959 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2016 | 15485 | 0.070 |
Why?
|
| Monosaccharides | 1 | 2006 | 66 | 0.070 |
Why?
|
| Cricetinae | 2 | 2012 | 2588 | 0.070 |
Why?
|
| Mannose | 1 | 2006 | 122 | 0.070 |
Why?
|
| Mutant Proteins | 1 | 2008 | 508 | 0.070 |
Why?
|
| Galactans | 1 | 2005 | 31 | 0.070 |
Why?
|
| Disease Progression | 2 | 2021 | 13298 | 0.070 |
Why?
|
| Interleukins | 1 | 2010 | 799 | 0.070 |
Why?
|
| Cell-Free System | 1 | 2006 | 370 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2021 | 21194 | 0.070 |
Why?
|
| Adjuvants, Immunologic | 2 | 2012 | 954 | 0.070 |
Why?
|
| Sigma Factor | 1 | 2006 | 171 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 6684 | 0.070 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2019 | 877 | 0.070 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1993 | 1017 | 0.070 |
Why?
|
| Acylation | 2 | 2018 | 115 | 0.070 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1993 | 2167 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 1712 | 0.070 |
Why?
|
| Golgi Apparatus | 2 | 2019 | 432 | 0.070 |
Why?
|
| Hydroxylation | 1 | 2004 | 137 | 0.060 |
Why?
|
| Genetic Complementation Test | 1 | 2004 | 586 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2011 | 4353 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2009 | 1719 | 0.060 |
Why?
|
| Adult | 14 | 2022 | 211041 | 0.060 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2005 | 250 | 0.060 |
Why?
|
| Hair | 1 | 2006 | 445 | 0.060 |
Why?
|
| Peptidoglycan | 1 | 2005 | 268 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2022 | 17218 | 0.060 |
Why?
|
| RNA | 1 | 2013 | 2680 | 0.060 |
Why?
|
| Cell Line, Transformed | 2 | 2021 | 989 | 0.060 |
Why?
|
| Immunity, Cellular | 1 | 2009 | 1693 | 0.060 |
Why?
|
| Staphylococcus | 1 | 2022 | 140 | 0.060 |
Why?
|
| Phylogeny | 2 | 2019 | 2799 | 0.060 |
Why?
|
| BCG Vaccine | 2 | 2022 | 354 | 0.060 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2002 | 57 | 0.060 |
Why?
|
| Major Histocompatibility Complex | 1 | 2006 | 1022 | 0.060 |
Why?
|
| Hybridomas | 1 | 2003 | 462 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 2277 | 0.060 |
Why?
|
| Phosphatidylethanolamines | 2 | 2017 | 139 | 0.060 |
Why?
|
| Blood Buffy Coat | 1 | 2021 | 8 | 0.060 |
Why?
|
| Capsaicin | 1 | 2003 | 235 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 3 | 2011 | 9584 | 0.060 |
Why?
|
| Binding, Competitive | 2 | 2019 | 1209 | 0.050 |
Why?
|
| Carbohydrate Sequence | 1 | 2001 | 416 | 0.050 |
Why?
|
| HeLa Cells | 3 | 2019 | 3258 | 0.050 |
Why?
|
| Hepatocytes | 2 | 2012 | 1242 | 0.050 |
Why?
|
| Armadillos | 1 | 2000 | 8 | 0.050 |
Why?
|
| Self Tolerance | 1 | 2001 | 125 | 0.050 |
Why?
|
| Dolichol Monophosphate Mannose | 1 | 2000 | 2 | 0.050 |
Why?
|
| Lysophospholipids | 2 | 2015 | 339 | 0.050 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2003 | 324 | 0.050 |
Why?
|
| Mycobacterium avium | 1 | 2000 | 30 | 0.050 |
Why?
|
| Female | 15 | 2021 | 375205 | 0.050 |
Why?
|
| Male | 15 | 2021 | 349524 | 0.050 |
Why?
|
| Gene Expression | 4 | 2019 | 8014 | 0.050 |
Why?
|
| Adenosine | 2 | 2016 | 842 | 0.050 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2003 | 432 | 0.050 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2000 | 93 | 0.050 |
Why?
|
| Patch Tests | 1 | 2020 | 53 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2019 | 3708 | 0.050 |
Why?
|
| Skin Care | 1 | 2020 | 53 | 0.050 |
Why?
|
| Liposomes | 2 | 2014 | 754 | 0.050 |
Why?
|
| Macrophages, Alveolar | 1 | 2022 | 441 | 0.050 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2019 | 39 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2005 | 1465 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2021 | 2750 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2013 | 4861 | 0.050 |
Why?
|
| Polysaccharides | 1 | 2006 | 991 | 0.050 |
Why?
|
| Diet | 1 | 2017 | 7392 | 0.050 |
Why?
|
| Cytokines | 4 | 2016 | 7189 | 0.050 |
Why?
|
| Cosmetics | 1 | 2020 | 84 | 0.050 |
Why?
|
| Esters | 1 | 2020 | 212 | 0.050 |
Why?
|
| Bronchi | 1 | 2003 | 845 | 0.040 |
Why?
|
| South Africa | 2 | 2015 | 1555 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 23284 | 0.040 |
Why?
|
| Endoribonucleases | 1 | 2020 | 219 | 0.040 |
Why?
|
| Culture Media | 1 | 2020 | 958 | 0.040 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2020 | 105 | 0.040 |
Why?
|
| Middle Aged | 8 | 2021 | 213752 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2022 | 677 | 0.040 |
Why?
|
| Mycobacterium marinum | 1 | 2017 | 22 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2005 | 1173 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 2164 | 0.040 |
Why?
|
| Typhoid Fever | 1 | 2019 | 163 | 0.040 |
Why?
|
| Kinetics | 2 | 2020 | 6796 | 0.040 |
Why?
|
| Mycobacterium phlei | 1 | 2016 | 3 | 0.040 |
Why?
|
| HIV Infections | 2 | 2015 | 15538 | 0.040 |
Why?
|
| Bacteroides fragilis | 1 | 2018 | 214 | 0.040 |
Why?
|
| beta 2-Microglobulin | 1 | 1998 | 332 | 0.040 |
Why?
|
| Rhodococcus equi | 1 | 2016 | 17 | 0.040 |
Why?
|
| DNA, Plant | 1 | 2016 | 50 | 0.040 |
Why?
|
| Biological Transport, Active | 2 | 2011 | 369 | 0.040 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2019 | 504 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 9556 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2008 | 4169 | 0.040 |
Why?
|
| Haploidy | 1 | 2016 | 155 | 0.040 |
Why?
|
| Plant Leaves | 1 | 2016 | 136 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2004 | 2838 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2015 | 1115 | 0.040 |
Why?
|
| Plant Extracts | 1 | 2020 | 456 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 1994 | 6338 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 4422 | 0.040 |
Why?
|
| Larva | 1 | 2017 | 513 | 0.040 |
Why?
|
| Phosphatidylcholines | 1 | 2017 | 438 | 0.040 |
Why?
|
| Diterpenes | 1 | 2016 | 180 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 2017 | 640 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2016 | 269 | 0.040 |
Why?
|
| Insect Bites and Stings | 1 | 2015 | 73 | 0.040 |
Why?
|
| Protein Footprinting | 1 | 2014 | 10 | 0.030 |
Why?
|
| Toxoplasma | 1 | 1996 | 148 | 0.030 |
Why?
|
| Demyelinating Diseases | 1 | 2017 | 368 | 0.030 |
Why?
|
| Phospholipases A2 | 1 | 2015 | 206 | 0.030 |
Why?
|
| Phosphatidylinositols | 2 | 2010 | 285 | 0.030 |
Why?
|
| Phenotype | 3 | 2021 | 16306 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2013 | 1777 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 16959 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2016 | 610 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2017 | 407 | 0.030 |
Why?
|
| Bacterial Typing Techniques | 1 | 2015 | 290 | 0.030 |
Why?
|
| Salts | 1 | 2014 | 55 | 0.030 |
Why?
|
| Genome, Bacterial | 2 | 2009 | 784 | 0.030 |
Why?
|
| Computational Biology | 2 | 2021 | 3568 | 0.030 |
Why?
|
| CD40 Ligand | 1 | 2015 | 533 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2019 | 1202 | 0.030 |
Why?
|
| Phytohemagglutinins | 1 | 1993 | 202 | 0.030 |
Why?
|
| Receptors, CCR5 | 1 | 2015 | 442 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 69553 | 0.030 |
Why?
|
| Myelin Sheath | 1 | 2017 | 656 | 0.030 |
Why?
|
| Leukapheresis | 1 | 1993 | 128 | 0.030 |
Why?
|
| HIV-1 | 1 | 2010 | 6757 | 0.030 |
Why?
|
| Sputum | 1 | 2015 | 472 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2014 | 214 | 0.030 |
Why?
|
| Feces | 1 | 2019 | 1365 | 0.030 |
Why?
|
| Phospholipases A2, Secretory | 1 | 2012 | 33 | 0.030 |
Why?
|
| Rats, Inbred Strains | 1 | 1994 | 2283 | 0.030 |
Why?
|
| History, 15th Century | 1 | 1992 | 34 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2016 | 970 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2012 | 224 | 0.030 |
Why?
|
| History, 16th Century | 1 | 1992 | 79 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 1956 | 0.030 |
Why?
|
| Immunity, Innate | 2 | 2022 | 2937 | 0.030 |
Why?
|
| Printing | 1 | 1992 | 56 | 0.030 |
Why?
|
| Immunodominant Epitopes | 1 | 2012 | 268 | 0.030 |
Why?
|
| Neuroglia | 1 | 2017 | 930 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1996 | 1499 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2014 | 577 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 1994 | 10525 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2014 | 1232 | 0.030 |
Why?
|
| Acute Disease | 1 | 2002 | 7158 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2012 | 288 | 0.030 |
Why?
|
| Mutation | 5 | 2019 | 29262 | 0.030 |
Why?
|
| Genotype | 2 | 2019 | 12863 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2016 | 2521 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 2203 | 0.030 |
Why?
|
| Molecular Typing | 1 | 2010 | 117 | 0.030 |
Why?
|
| Intracellular Fluid | 2 | 2000 | 214 | 0.030 |
Why?
|
| Desensitization, Immunologic | 1 | 2015 | 484 | 0.030 |
Why?
|
| Mycobacterium avium subsp. paratuberculosis | 1 | 2009 | 4 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 916 | 0.020 |
Why?
|
| Secretory Pathway | 1 | 2009 | 58 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2016 | 2690 | 0.020 |
Why?
|
| Inflammation | 1 | 2009 | 10019 | 0.020 |
Why?
|
| Germany | 1 | 1992 | 791 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 2864 | 0.020 |
Why?
|
| Lipid Bilayers | 1 | 2012 | 391 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 2014 | 1142 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 1994 | 2165 | 0.020 |
Why?
|
| Lymphocyte Subsets | 1 | 2010 | 325 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2019 | 2587 | 0.020 |
Why?
|
| Body Temperature | 1 | 2012 | 781 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1993 | 1670 | 0.020 |
Why?
|